An in vitro vascularized micro-tumor model of human colorectal cancer recapitulates in vivo responses to standard-of-care therapy
Open accessPublished version of a preprint
The DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index.
Abstract
Around 95% of anti-cancer drugs that show promise during preclinical study fail to gain FDA-approval for clinical use. This failure of the preclinical pipeline highlights the need for improved, physiologically-relevant in vitro models that can better serve as reliable drug-screening and disease modeling tools. The vascularized micro-tumor (VMT) is a novel three-dimensional model system (tumor-on-a-chip) that recapitulates the complex human tumor microenvironment, including perfused vasculature, within a transparent microfluidic device, allowing real-time study of drug responses and tumor-stromal interactions. Here we have validated this microphysiological system (MPS) platform for the study of colorectal cancer (CRC), the second leading cause of cancer-related deaths, by showing that gene expression, tumor heterogeneity, and treatment responses in the VMT more closely model CRC tumor clinicopathology than current standard drug screening modalities, including 2-dimensional monolayer culture and 3-dimensional spheroids.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures








Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In contrast to all of this, novel multicellular three-dimensional (3D) in vitro models can bridge the gap between experimental controllability and physiological relevance via reliably reproducing tissue or tumor architecture, mimicking tissue stiffness, allowing cellular crosstalk via the integration of multiple cell types and replicating various physical, morphological, structural, mechanical and”
From Microphysiological systems as models for immunologically ‘cold’ tumors (2024) · cites this paper as Hachey et al., 2021
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Notably, these physiologically relevant platforms have previously shown promise in drug discovery and testing by faithfully recapitulating pathophysiological human drug responses (Asghar et al., 2015; Benam et al., 2016; Hachey et al., 2021); hence offering the potential to advance the development of personalized therapy approaches.”
From Microphysiological systems as models for immunologically ‘cold’ tumors (2024) · cites this paper as Hachey et al., 2021
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“To date, MPS models have been developed for the majority of human tissues and organs, and have also been established to study a diverse range of malignancies, including cancer (Baptista et al., 2022; Hachey et al. (2021; 2024); Jiang et al., 2024; Haque et al., 2022; Shen et al., 2023; Flont et al., 2023; Straehla et al., 2022).”
From Microphysiological systems as models for immunologically ‘cold’ tumors (2024) · cites this paper as Hachey et al., 2021
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The model has been adapted to multiple cancer types, including immunologically ‘cold’ or ‘mixed’ tumors such as breast cancer, MSS subtype colorectal cancer and ovarian cancer, which display varying degrees of vascular disruption (Jahid et al., 2022; Hachey et al., 2024), Hachey et al. (2021)).”
From Microphysiological systems as models for immunologically ‘cold’ tumors (2024) · cites this paper as Hachey et al., 2021
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Tumor chips have been developed to model a broad variety of cancers, including primary lung cancer, prostate cancer, breast cancer, colorectal cancer, pancreatic cancer, melanoma, liver cancer and glioblastoma (among other cancers), as well as cancer metastasis to the bone, the brain, the liver and the lung (Hachey et al. (2021; 2024); Jiang et al. (2024); Haque et al. (2022); Shen et al. (2023);”
From Microphysiological systems as models for immunologically ‘cold’ tumors (2024) · cites this paper as Hachey et al., 2021
1 more claim about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Siegel, R. L., Miller, K. D., & Jemal, A. (2019) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21551 · Cited by 20,160
Comprehensive Integration of Single-Cell Data
Stuart, T., Butler, A., Hoffman, P., Hafemeister, C., Papalexi, E., Mauck, W. M., Hao, Y., Stoeckius, M., Smibert, P., & Satija, R. (2019) · Cell · doi:10.1016/j.cell.2019.05.031 · Cited by 15,453
Integrating single-cell transcriptomic data across different conditions, technologies, and species
Butler, A., Hoffman, P., Smibert, P., Papalexi, E., & Satija, R. (2018) · Nature Biotechnology · doi:10.1038/nbt.4096 · Cited by 13,174
dbSNP: the NCBI database of genetic variation
Sherry, S. T. (2001) · Nucleic Acids Research · doi:10.1093/nar/29.1.308 · Cited by 7,502
Trapnell, C., Cacchiarelli, D., Grimsby, J., Pokharel, P., Li, S., Morse, M., Lennon, N. J., Livak, K. J., Mikkelsen, T. S., & Rinn, J. L. (2014) · Nature Biotechnology · doi:10.1038/nbt.2859 · Cited by 7,314
Molecular mechanisms and clinical applications of angiogenesis
Carmeliet, P., & Jain, R. K. (2011) · Nature · doi:10.1038/nature10144 · Cited by 5,467
Matrix Metalloproteinases: Regulators of the Tumor Microenvironment
Kessenbrock, K., Plaks, V., & Werb, Z. (2010) · Cell · doi:10.1016/j.cell.2010.03.015 · Cited by 5,151
Self-citationMassagué, J. (2008) · Cell · doi:10.1016/j.cell.2008.07.001 · Cited by 3,907
Wnt signalling in stem cells and cancer
Reya, T., & Clevers, H. (2005) · Nature · doi:10.1038/nature03319 · Cited by 3,666
Next-generation characterization of the Cancer Cell Line Encyclopedia
Ghandi, M., Huang, F. W., Jané-Valbuena, J., Kryukov, G. V., Lo, C. C., McDonald, E. R., Barretina, J., Gelfand, E. T., Bielski, C. M., Li, H., et al. (2019) · Nature · doi:10.1038/s41586-019-1186-3 · Cited by 3,394
The extracellular matrix: A dynamic niche in cancer progression
Lu, P., Weaver, V. M., & Werb, Z. (2012) · Journal of Cell Biology · doi:10.1083/jcb.201102147 · Cited by 3,024
Molecular regulation of vessel maturation
Jain, R. K. (2003) · Nature Medicine · doi:10.1038/nm0603-685 · Cited by 2,529
Capturing complex 3D tissue physiology in vitro
Griffith, L. G., & Swartz, M. A. (2006) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1858 · Cited by 2,290
The extracellular matrix modulates the hallmarks of cancer
Pickup, M. W., Mouw, J. K., & Weaver, V. M. (2014) · EMBO reports · doi:10.15252/embr.201439246 · Cited by 1,996
Wnt activity defines colon cancer stem cells and is regulated by the microenvironment
Vermeulen, L., De Sousa E Melo, F., van der Heijden, M., Cameron, K., de Jong, J. H., Borovski, T., Tuynman, J. B., Todaro, M., Merz, C., Rodermond, H., et al. (2010) · Nature Cell Biology · doi:10.1038/ncb2048 · Cited by 1,804
CellMarker: a manually curated resource of cell markers in human and mouse
Zhang, X., Lan, Y., Xu, J., Quan, F., Zhao, E., Deng, C., Luo, T., Xu, L., Liao, G., Yan, M., et al. (2019) · Nucleic Acids Research · doi:10.1093/nar/gky900 · Cited by 1,524
Dependency of Colorectal Cancer on a TGF-β-Driven Program in Stromal Cells for Metastasis Initiation
Calon, A., Espinet, E., Palomo-Ponce, S., Tauriello, D. V. F., Iglesias, M., Céspedes, M. V., Sevillano, M., Nadal, C., Jung, P., Zhang, X. H.-F., et al. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.08.013 · Cited by 1,060
Single-cell analysis reveals a stem-cell program in human metastatic breast cancer cells
Lawson, D. A., Bhakta, N. R., Kessenbrock, K., Prummel, K. D., Yu, Y., Takai, K., Zhou, A., Eyob, H., Balakrishnan, S., Wang, C.-Y., et al. (2015) · Nature · doi:10.1038/nature15260 · Cited by 893
Environment-mediated drug resistance: A major contributor to minimal residual disease
Meads, M. B., Gatenby, R. A., & Dalton, W. S. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2714 · Cited by 892
Cassidy, J., Clarke, S., Díaz-Rubio, E., Scheithauer, W., Figer, A., Wong, R., Koski, S., Lichinitser, M., Yang, T.-S., Rivera, F., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.14.9898 · Cited by 862
Three-Dimensional Cell Cultures in Drug Discovery and Development
Fang, Y., & Eglen, R. M. (2017) · SLAS Discovery · doi:10.1177/1087057117696795 · Cited by 849
High drug attrition rates—where are we going wrong?
Hutchinson, L., & Kirk, R. (2011) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2011.34 · Cited by 517
In vivo vasculogenic potential of human blood-derived endothelial progenitor cells
Melero-Martin, J. M., Khan, Z. A., Picard, A., Wu, X., Paruchuri, S., & Bischoff, J. (2007) · Blood · doi:10.1182/blood-2006-12-062471 · Cited by 501
Nakasone, E. S., Askautrud, H. A., Kees, T., Park, J.-H., Plaks, V., Ewald, A. J., Fein, M., Rasch, M. G., Tan, Y.-X., Qiu, J., et al. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.02.017 · Cited by 478
Wnt signaling directs a metabolic program of glycolysis and angiogenesis in colon cancer
Pate, K. T., Stringari, C., Sprowl‐Tanio, S., Wang, K., TeSlaa, T., Hoverter, N. P., McQuade, M. M., Garner, C., Digman, M. A., Teitell, M. A., et al. (2014) · The EMBO Journal · doi:10.15252/embj.201488598 · Cited by 459
Self-citationThe tumor microenvironment is a dominant force in multidrug resistance
Correia, A. L., & Bissell, M. J. (2012) · Drug Resistance Updates · doi:10.1016/j.drup.2012.01.006 · Cited by 443
In Vitro Perfused Human Capillary Networks
Moya, M. L., Hsu, Y.-H., Lee, A. P., Hughes, C. C. W., & George, S. C. (2013) · Tissue Engineering Part C: Methods · doi:10.1089/ten.tec.2012.0430 · Cited by 387
3D microtumors in vitro supported by perfused vascular networks
Sobrino, A., Phan, D. T. T., Datta, R., Wang, X., Hachey, S. J., Romero-López, M., Gratton, E., Lee, A. P., George, S. C., & Hughes, C. C. W. (2016) · Scientific Reports · doi:10.1038/srep31589 · Cited by 387
Self-citationA Multicolor Panel of Novel Lentiviral “Gene Ontology” (LeGO) Vectors for Functional Gene Analysis
Weber, K., Bartsch, U., Stocking, C., & Fehse, B. (2008) · Molecular Therapy · doi:10.1038/mt.2008.6 · Cited by 351
Examining the utility of patient-derived xenograft mouse models
Aparicio, S., Hidalgo, M., & Kung, A. L. (2015) · Nature Reviews Cancer · doi:10.1038/nrc3944 · Cited by 345
A vascularized and perfused organ-on-a-chip platform for large-scale drug screening applications
Phan, D. T. T., Wang, X., Craver, B. M., Sobrino, A., Zhao, D., Chen, J. C., Lee, L. Y. N., George, S. C., Lee, A. P., & Hughes, C. C. W. (2017) · Lab on a Chip · doi:10.1039/c6lc01422d · Cited by 325
Self-citationSynergistic Engineering: Organoids Meet Organs-on-a-Chip
Takebe, T., Zhang, B., & Radisic, M. (2017) · Cell Stem Cell · doi:10.1016/j.stem.2017.08.016 · Cited by 258
Jeon, J. S., Bersini, S., Whisler, J. A., Chen, M. B., Dubini, G., Charest, J. L., Moretti, M., & Kamm, R. D. (2014) · Integr. Biol. · doi:10.1039/c3ib40267c · Cited by 233
Woodford-Richens, K. L., Rowan, A. J., Gorman, P., Halford, S., Bicknell, D. C., Wasan, H. S., Roylance, R. R., Bodmer, W. F., & Tomlinson, I. P. M. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.171321498 · Cited by 199
Hsu, Y.-H., Moya, M. L., Hughes, C. C. W., George, S. C., & Lee, A. P. (2013) · Lab on a Chip · doi:10.1039/c3lc50424g · Cited by 192
Lessons from patient-derived xenografts for better in vitro modeling of human cancer
Choi, S. Y. C., Lin, D., Gout, P. W., Collins, C. C., Xu, Y., & Wang, Y. (2014) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2014.09.009 · Cited by 177
Cell lineage and communication network inference via optimization for single-cell transcriptomics
Wang, S., Karikomi, M., MacLean, A. L., & Nie, Q. (2019) · Nucleic Acids Research · doi:10.1093/nar/gkz204 · Cited by 154
Heterogeneous Vascular Dependence of Tumor Cell Populations
Yu, J., Rak, J. W., Carmeliet, P., Nagy, A., Kerbel, R. S., & Coomber, B. L. (2001) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)64083-7 · Cited by 150
Mena, M. A., Treynor, T. P., Mayo, S. L., & Daugherty, P. S. (2006) · Nature Biotechnology · doi:10.1038/nbt1264 · Cited by 140
Fong, A. H., Romero-López, M., Heylman, C. M., Keating, M., Tran, D., Sobrino, A., Tran, A. Q., Pham, H. H., Fimbres, C., Gershon, P. D., et al. (2016) · Tissue Engineering Part A · doi:10.1089/ten.tea.2016.0027 · Cited by 140
Applications of tumor chip technology
Hachey, S. J., & Hughes, C. C. W. (2018) · Lab on a Chip · doi:10.1039/c8lc00330k · Cited by 128
Romero-López, M., Trinh, A. L., Sobrino, A., Hatch, M. M. S., Keating, M. T., Fimbres, C., Lewis, D. E., Gershon, P. D., Botvinick, E. L., Digman, M., et al. (2017) · Biomaterials · doi:10.1016/j.biomaterials.2016.11.034 · Cited by 125
Self-citationFull range physiological mass transport control in 3D tissue cultures
Hsu, Y.-H., Moya, M. L., Abiri, P., Hughes, C. C. W., George, S. C., & Lee, A. P. (2013) · Lab Chip · doi:10.1039/c2lc40787f · Cited by 124
Kehlet, S. N., Sanz-Pamplona, R., Brix, S., Leeming, D. J., Karsdal, M. A., & Moreno, V. (2016) · Scientific Reports · doi:10.1038/srep30599 · Cited by 113
Neuroendocrine differentiation is a relevant prognostic factor in stage III–IV colorectal cancer
Grabowski, P., Schindler, I., Anagnostopoulos, I., Foss, H., Riecken, E., Mansmann, U., Stein, H., Berger, G., Buhr, H. J., & Scherübl, H. (2001) · European Journal of Gastroenterology & Hepatology · doi:10.1097/00042737-200104000-00018 · Cited by 87
Keratin 23 promotes telomerase reverse transcriptase expression and human colorectal cancer growth
Zhang, N., Zhang, R., Zou, K., Yu, W., Guo, W., Gao, Y., Li, J., Li, M., Tai, Y., Huang, W., et al. (2017) · Cell Death and Disease · doi:10.1038/cddis.2017.339 · Cited by 70
Ricciardelli, C., Lokman, N. A., Pyragius, C. E., Ween, M. P., Macpherson, A. M., Ruszkiewicz, A. R., Hoffmann, P., & Oehler, M. K. (2017) · Oncotarget · doi:10.18632/oncotarget.14867 · Cited by 61
Heylman, C., Sobrino, A., Shirure, V. S., Hughes, C. C., & George, S. C. (2014) · Experimental Biology and Medicine · doi:10.1177/1535370214525295 · Cited by 53
Self-citationLiu, Y., He, J., Xu, J., Li, J., Jiao, Y., Bei, D., Hu, Y., Chen, H., Xiao, Q., & Ding, K. (2017) · Oncology Letters · doi:10.3892/ol.2017.5681 · Cited by 18
enrichR: Provides an R Interface to 'Enrichr'
Jawaid, W. (2017) · doi:10.32614/cran.package.enrichr · Cited by 14
Research works printed but not linked: 4
- RStudio Team, RStudio: Integrated Development Environment for R, RStudio, Inc., Boston, MA, 2016
- 10XGenomics, Vartrix single-cell genotyping tool
- Tickle T., Tirosh I., Georgescu C., Brown M. and Haas B., inferCNV of the Trinity CTAT Project, Klarman Cell Observatory, Broad Institute of MIT and Harvard, Cambridge, MA, USA, 2019
- Sharma G. and Stein-O'Brien G., projectR: Functions for the projection of weights from PCA, CoGAPS, NMF, correlation, and clustering, 2016
Cited by
Human organs-on-chips for disease modelling, drug development and personalized medicine
Ingber, D. E. (2022) · Nature Reviews Genetics · doi:10.1038/s41576-022-00466-9 · Cited by 1,589
Thorel, L., Perréard, M., Florent, R., Divoux, J., Coffy, S., Vincent, A., Gaggioli, C., Guasch, G., Gidrol, X., Weiswald, L.-B., et al. (2024) · Experimental & Molecular Medicine · doi:10.1038/s12276-024-01272-5 · Cited by 236
“To date, numerous researchers have developed their own organoids-on-chip systems 145,147 – 149 , whereas others have used commercially available chips 150,151 .”
BackgroundEngineering Vascularized Organoid-on-a-Chip Models
Shirure, V. S., Hughes, C. C. W., & George, S. C. (2021) · Annual Review of Biomedical Engineering · doi:10.1146/annurev-bioeng-090120-094330 · Cited by 193
Tumor-on-chip modeling of organ-specific cancer and metastasis
Del Piccolo, N., Shirure, V. S., Bi, Y., Goedegebuure, S. P., Gholami, S., Hughes, C. C. W., Fields, R. C., & George, S. C. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.05.008 · Cited by 126
Organ-on-a-chip systems for vascular biology
Mandrycky, C., Howard, C. C., Rayner, S. G., Shin, Y. J., & Zheng, Y. Y. (2021) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2021.06.002 · Cited by 107
Metadata
- Authors
- Hachey, S. J., Movsesyan, S., Nguyen, Q. H., Burton-Sojo, G., Tankazyan, A., Wu, J., Hoang, T., Zhao, D., Wang, S., Hatch, M. M., Celaya, E., Gomez, S., Chen, G. T., Davis, R. T., Nee, K., Pervolarakis, N., Lawson, D. A., Kessenbrock, K., Lee, A. P., Lowengrub, J., Waterman, M. L., & Hughes, C. C. W.
- Affiliations
- University of California, Irvine (US)
- Department of Molecular Biology and Biochemistry
- Corresponding author
- Hughes, Christopher C. W.
- ORCID
- Venue
- Lab on a Chip
- Publisher
- Royal Society of Chemistry (RSC)
- Published
- 2021
- Volume
- 21
- Issue
- 7
- Pages
- 1333-1351
- ISSN
- 1473-0189 (ISSN-L)
- 1473-0197
- PMC
- PMC8525497
- OpenAlex
- W3130617653
- Cited by
- 124
- References
- 50
- Citations by year
- 2026: 19 · 2025: 21 · 2024: 30 · 2023: 24 · 2022: 18 · 2021: 11
- FWCI
- 6.53
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Lab on a Chip (publishedVersion, cc-by-nc)
- bioRxiv (Cold Spring Harbor Laboratory) (acceptedVersion)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- Funders
- Edwards Lifesciences
- Chao Family Comprehensive Cancer Center (P30A062203)
- National Institutes of Health (CA217378, CA180122, TR-000481)
- Topics
- Physical Sciences › Engineering › Biomedical Engineering › 3D Printing in Biomedical Research
- Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
- Physical Sciences › Engineering › Biomedical Engineering › Microfluidic and Capillary Electrophoresis Applications
- Keywords
- colorectal cancer, tumor-on-a-chip, microphysiological systems, microfluidics, tumor microenvironment, drug screening, tumor heterogeneity, tumor-stroma interactions, preclinical model validation, multicellular spheroids, gene expression
- MeSH terms
- Antineoplastic Agents, Drug Evaluation, Preclinical, Humans, Colorectal Neoplasms, Lab-On-A-Chip Devices, Tumor Microenvironment
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.